Synbio Tech Inc. (TPEX:1295)

Market Cap	5.10B
Revenue (ttm)	1.06B
Net Income (ttm)	180.49M
Shares Out	34.47M
EPS (ttm)	5.68
PE Ratio	26.07
Forward PE	21.51
Dividend	3.50 (2.46%)
Ex-Dividend Date	Mar 27, 2025

Volume	2,516,692
Average Volume	1,859,490
Open	149.00
Previous Close	148.00
Day's Range	145.00 - 149.50
52-Week Range	58.50 - 152.00
Beta	n/a
RSI	73.05
Earnings Date	Aug 8, 2025

About Synbio Tech

Synbio Tech Inc. engages in the manufacturing of human healthcare and the research on probiotics for economic animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. It also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improv...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 92
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1295

Financial Performance

In 2024, Synbio Tech's revenue was 989.48 million, an increase of 20.18% compared to the previous year's 823.30 million. Earnings were 170.13 million, an increase of 50.19%.